Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Targeting HER2-positive cancer cells with receptor-redirected anthrax protective antigen.
See All Pages
Find People
Find Everything
Edit My Profile
My Person List (
0
)
Opportunity Search
Due to system maintenance, login and edit functionaility is currently unavailable
Return to Top
Targeting HER2-positive cancer cells with receptor-redirected anthrax protective antigen.
Targeting HER2-positive cancer cells with receptor-redirected anthrax protective antigen. Mol Oncol. 2013 Jun; 7(3):440-51.
View in:
PubMed
subject areas
Antigens, Bacterial
Bacterial Toxins
Cell Death
Cell Line, Tumor
Cell Survival
Drug Delivery Systems
Drug Resistance, Neoplasm
Humans
Neoplasms
Receptor, erbB-2
Recombinant Fusion Proteins
authors with profiles
Michael N. Starnbach, Ph.D.
R. John Collier, Ph.D.